Skip navigation.

Welcome to SAfAIDS

TB, is the world’s top infectious disease killer, claiming 5 000 lives each day. The heaviest burden is carried by communities already facing socio-economic challenges such as  migrants, refugees, prisoners, ethnic minorities, miners and others working and living in risk-prone settings, and marginalized women, children and older people (WHO: 2017).

SAfAIDS news

HIV treatment figures up by 42% - UNAIDS

Some 3 million people now have access to antiretroviral therapy according to a report issued today by WHO, UNAIDS and UNICEF. Towards Universal Access: Scaling Up Priority HIV and AIDS Interventions in the Health Sector was launched in Geneva by Dr Margaret Chan, WHO Director-General.

HIV treatment figures up by 42% - UNAIDS

Some 3 million people now have access to antiretroviral therapy according to a report issued today by WHO, UNAIDS and UNICEF. Towards Universal Access: Scaling Up Priority HIV and AIDS Interventions in the Health Sector was launched in Geneva by Dr Margaret Chan, WHO Director-General.

“HIV and TB Co-infection: A Deadly Marriage” - SAfAIDS Discussion Forum

A cursed duet is what others called it. HIV and TB co-infection was the focus of the recently held SAfAIDS discussion forum at the Jameson Hotel yesterday afternoon. The discussions centred on the intricacies surrounding HIV and TB co-infection including the challenges experienced in rural areas by home based care practitioners.

The Community Prepardness Programme in Zambia

In 2004, SAfAIDS started implementing a programme to complement national efforts to scale up uptake of ART through enhanced community preparedness and advocacy in Zambia. The main objective of the project was to increase community's literacy on HIV treatment and to influence national policy to make access to treatment easier.

Using the Law to address HIV and AIDS related Stigma and Discrimination - SAfAIDS Discussion Forum

On Friday 30 March 2007, SAfAIDS held a discussion forum entitled, "Using the law to address HIV and AIDS-related stigma and discrimination".

CIMAS suspends ARV drug facility - The Herald

Herald Reporter -Zimbabwe's leading medical aid service provider, CIMAS has suspended its anti-retroviral drug facility because of foreign currency shortages.

CIMAS spokesperson Ms Lindiwe Mhunduru said the company had stopped issuing ARVs because they were not available on the market.

Syndicate content